• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CGA
Click for more information
0.00% $1.00

CONTANGO ASSET MANAGEMENT LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
CGAAppendix 4C - quarterlyPRICE SENSITIVE23/10/12
CGAAnnual Report to shareholders19/10/12
CGANotice of Annual General Meeting19/10/12
CGAPreliminary Final ReportPRICE SENSITIVE30/08/12
CGAAppendix 4C - quarterlyPRICE SENSITIVE30/07/12
CGABecoming a substantial holder11/07/12
CGAAppendix 4C - quarterlyPRICE SENSITIVE26/04/12
CGATyrian and Bayer Agreement and Non-Exclusive LicencePRICE SENSITIVE26/04/12
CGABecoming a substantial holder23/03/12
CGAJ Harry Final Director's Interest Notice24/02/12
CGAChange of Director's Interest Notice24/02/12
CGACompany UpdatePRICE SENSITIVE24/02/12
CGAHalf Yearly Report and AccountsPRICE SENSITIVE24/02/12
CGAAppendix 4C - quarterlyPRICE SENSITIVE31/01/12
CGATyrian signs Distribution Agreement for its TB AntibodiesPRICE SENSITIVE19/12/11
CGATyrian Licenses TB Biomarker12/12/11
CGADeparture of CFO and Assistant Company Secretary24/11/11
CGAResults of Meeting23/11/11
CGACEO AGM Presentation 201123/11/11
CGADetails of Company Address14/11/11
CGAAnnual Report to shareholders31/10/11
CGAAppendix 4C - quarterlyPRICE SENSITIVE25/10/11
CGANotice of Annual General Meeting24/10/11
CGADate of 2011 Annual General Meeting23/09/11
CGAPreliminary Final ReportPRICE SENSITIVE31/08/11
CGABayer Agreements and Revision of Corporate StrategyPRICE SENSITIVE24/08/11
CGAAppendix 4C - quarterlyPRICE SENSITIVE28/07/11
CGAReplacement - Change of Director's Interest Notice19/07/11
CGAChange of Director's Interest Notice18/07/11
CGAAppendix 3B18/07/11
CGAAdvancements on Milestones for 2011PRICE SENSITIVE01/07/11
CGAAppendix 4C - quarterlyPRICE SENSITIVE19/04/11
CGAChange in substantial holding11/04/11
CGAHalf Yearly Report and AccountsPRICE SENSITIVE25/02/11
CGAAppendix 3B14/02/11
CGAAppendix 4C - quarterlyPRICE SENSITIVE27/01/11
CGAChange of Director's Interest Notice24/12/10
CGAChange of Director's Interest Notice24/12/10
CGAChange of Director's Interest Notice24/12/10
CGAAppendix 3B24/12/10
CGATyrian completes Rights Issue15/12/10
CGAConfirmation of Despatch of Prospectus for Rights Issue29/11/10
CGAResults of AGM29/11/10
CGACEO Presentation 2010 AGM29/11/10
CGAAppendix 3B18/11/10
CGAReinstatement to Official QuotationPRICE SENSITIVE18/11/10
CGAInvestor Presentation Rights Issue18/11/10
CGALetter to Optionholders18/11/10
CGALetter to Shareholders18/11/10
CGATyrian Announces Rights IssuePRICE SENSITIVE18/11/10
CGAProspectus - Rights IssuePRICE SENSITIVE18/11/10
CGASuspensionPRICE SENSITIVE17/11/10
CGATrading HaltPRICE SENSITIVE15/11/10
CGANotice of Annual General Meeting29/10/10
CGATyrian Diagnostics 2010 Annual Report to shareholders29/10/10
CGAAppendix 4C - quarterlyPRICE SENSITIVE27/10/10
CGA2010 AGM Date - Revised20/10/10
CGAGrant of Waiver to Listing Rules 10.13.3 and 10.13.512/10/10
CGA2010 AGM Date07/10/10
CGATyrian ships first commercial order23/09/10
CGATyrian TB marker validated for molecular diagnosticPRICE SENSITIVE03/09/10
CGAPreliminary Final ReportPRICE SENSITIVE01/09/10
CGAAppendix 4C - quarterlyPRICE SENSITIVE29/07/10
CGACompany Newsletter - June 201001/07/10
CGATyrian Appoints Manufacturer of Diagnostic Tests28/06/10
CGATyrian signs supply agreement with Bayer CropSciencePRICE SENSITIVE16/06/10
CGAAppendix 4C - quarterlyPRICE SENSITIVE29/04/10
CGAHalf Yearly Report and AccountsPRICE SENSITIVE23/02/10
CGAResponse to ASX Price QueryPRICE SENSITIVE14/01/10
CGAAppendix 4C - quarterlyPRICE SENSITIVE12/01/10
CGAAppointment of New Chief Financial Officer06/01/10
CGAAppendix 3B24/12/09
CGATyrian Announces Progress on New Diagnostic TestPRICE SENSITIVE24/11/09
CGARESULTS OF AGM 200911/11/09
CGACEO AGM 2009 Presentation11/11/09
CGAChange in substantial holding29/10/09
CGATyrian and BD discontinue collaboration for TBPRICE SENSITIVE15/10/09
CGAAppendix 4C - quarterlyPRICE SENSITIVE13/10/09
CGATyrian Diagnostics Proxy form for 2009 AGM12/10/09
CGANotice of Annual General Meeting12/10/09
CGAChange of Director's Interest Notice08/09/09
CGAChange of Director's Interest Notice08/09/09
CGACeasing to be a substantial holder08/09/09
CGAAppendix 3B04/09/09
CGAFIRST SALES OF READRITE IMMUNOSCANNER TO BAYERPRICE SENSITIVE02/09/09
CGATyrian Completes Rights Issue31/08/09
CGATyrian Diagnostics 2009 Annual Report to shareholders27/08/09
CGATyrian Diagnostics - 2009 Appendix 4EPRICE SENSITIVE27/08/09
CGAConfirmation of Despatch of Prospectus13/08/09
CGAChange of Director's Interest Notice10/08/09
CGALetter to Shareholders04/08/09
CGAAppendix 3B31/07/09
CGAInvestor Presentation31/07/09
CGAProspectusPRICE SENSITIVE31/07/09
CGATyrian Announces Rights IssuePRICE SENSITIVE31/07/09
CGAAppendix 4CPRICE SENSITIVE31/07/09
CGATrading HaltPRICE SENSITIVE29/07/09
CGACompany Newsletter - July 200913/07/09
CGACeasing to be a substantial holder15/06/09
CGAChange in substantial holding12/06/09
CGAAppendix 4C - quarterly
23/10/12PRICE SENSITIVE
CGAAnnual Report to shareholders
19/10/12
CGANotice of Annual General Meeting
19/10/12
CGAPreliminary Final Report
30/08/12PRICE SENSITIVE
CGAAppendix 4C - quarterly
30/07/12PRICE SENSITIVE
CGABecoming a substantial holder
11/07/12
CGAAppendix 4C - quarterly
26/04/12PRICE SENSITIVE
CGATyrian and Bayer Agreement and Non-Exclusive Licence
26/04/12PRICE SENSITIVE
CGABecoming a substantial holder
23/03/12
CGAJ Harry Final Director's Interest Notice
24/02/12
CGAChange of Director's Interest Notice
24/02/12
CGACompany Update
24/02/12PRICE SENSITIVE
CGAHalf Yearly Report and Accounts
24/02/12PRICE SENSITIVE
CGAAppendix 4C - quarterly
31/01/12PRICE SENSITIVE
CGATyrian signs Distribution Agreement for its TB Antibodies
19/12/11PRICE SENSITIVE
CGATyrian Licenses TB Biomarker
12/12/11
CGADeparture of CFO and Assistant Company Secretary
24/11/11
CGAResults of Meeting
23/11/11
CGACEO AGM Presentation 2011
23/11/11
CGADetails of Company Address
14/11/11
CGAAnnual Report to shareholders
31/10/11
CGAAppendix 4C - quarterly
25/10/11PRICE SENSITIVE
CGANotice of Annual General Meeting
24/10/11
CGADate of 2011 Annual General Meeting
23/09/11
CGAPreliminary Final Report
31/08/11PRICE SENSITIVE
CGABayer Agreements and Revision of Corporate Strategy
24/08/11PRICE SENSITIVE
CGAAppendix 4C - quarterly
28/07/11PRICE SENSITIVE
CGAReplacement - Change of Director's Interest Notice
19/07/11
CGAChange of Director's Interest Notice
18/07/11
CGAAppendix 3B
18/07/11
CGAAdvancements on Milestones for 2011
01/07/11PRICE SENSITIVE
CGAAppendix 4C - quarterly
19/04/11PRICE SENSITIVE
CGAChange in substantial holding
11/04/11
CGAHalf Yearly Report and Accounts
25/02/11PRICE SENSITIVE
CGAAppendix 3B
14/02/11
CGAAppendix 4C - quarterly
27/01/11PRICE SENSITIVE
CGAChange of Director's Interest Notice
24/12/10
CGAChange of Director's Interest Notice
24/12/10
CGAChange of Director's Interest Notice
24/12/10
CGAAppendix 3B
24/12/10
CGATyrian completes Rights Issue
15/12/10
CGAConfirmation of Despatch of Prospectus for Rights Issue
29/11/10
CGAResults of AGM
29/11/10
CGACEO Presentation 2010 AGM
29/11/10
CGAAppendix 3B
18/11/10
CGAReinstatement to Official Quotation
18/11/10PRICE SENSITIVE
CGAInvestor Presentation Rights Issue
18/11/10
CGALetter to Optionholders
18/11/10
CGALetter to Shareholders
18/11/10
CGATyrian Announces Rights Issue
18/11/10PRICE SENSITIVE
CGAProspectus - Rights Issue
18/11/10PRICE SENSITIVE
CGASuspension
17/11/10PRICE SENSITIVE
CGATrading Halt
15/11/10PRICE SENSITIVE
CGANotice of Annual General Meeting
29/10/10
CGATyrian Diagnostics 2010 Annual Report to shareholders
29/10/10
CGAAppendix 4C - quarterly
27/10/10PRICE SENSITIVE
CGA2010 AGM Date - Revised
20/10/10
CGAGrant of Waiver to Listing Rules 10.13.3 and 10.13.5
12/10/10
CGA2010 AGM Date
07/10/10
CGATyrian ships first commercial order
23/09/10
CGATyrian TB marker validated for molecular diagnostic
03/09/10PRICE SENSITIVE
CGAPreliminary Final Report
01/09/10PRICE SENSITIVE
CGAAppendix 4C - quarterly
29/07/10PRICE SENSITIVE
CGACompany Newsletter - June 2010
01/07/10
CGATyrian Appoints Manufacturer of Diagnostic Tests
28/06/10
CGATyrian signs supply agreement with Bayer CropScience
16/06/10PRICE SENSITIVE
CGAAppendix 4C - quarterly
29/04/10PRICE SENSITIVE
CGAHalf Yearly Report and Accounts
23/02/10PRICE SENSITIVE
CGAResponse to ASX Price Query
14/01/10PRICE SENSITIVE
CGAAppendix 4C - quarterly
12/01/10PRICE SENSITIVE
CGAAppointment of New Chief Financial Officer
06/01/10
CGAAppendix 3B
24/12/09
CGATyrian Announces Progress on New Diagnostic Test
24/11/09PRICE SENSITIVE
CGARESULTS OF AGM 2009
11/11/09
CGACEO AGM 2009 Presentation
11/11/09
CGAChange in substantial holding
29/10/09
CGATyrian and BD discontinue collaboration for TB
15/10/09PRICE SENSITIVE
CGAAppendix 4C - quarterly
13/10/09PRICE SENSITIVE
CGATyrian Diagnostics Proxy form for 2009 AGM
12/10/09
CGANotice of Annual General Meeting
12/10/09
CGAChange of Director's Interest Notice
08/09/09
CGAChange of Director's Interest Notice
08/09/09
CGACeasing to be a substantial holder
08/09/09
CGAAppendix 3B
04/09/09
CGAFIRST SALES OF READRITE IMMUNOSCANNER TO BAYER
02/09/09PRICE SENSITIVE
CGATyrian Completes Rights Issue
31/08/09
CGATyrian Diagnostics 2009 Annual Report to shareholders
27/08/09
CGATyrian Diagnostics - 2009 Appendix 4E
27/08/09PRICE SENSITIVE
CGAConfirmation of Despatch of Prospectus
13/08/09
CGAChange of Director's Interest Notice
10/08/09
CGALetter to Shareholders
04/08/09
CGAAppendix 3B
31/07/09
CGAInvestor Presentation
31/07/09
CGAProspectus
31/07/09PRICE SENSITIVE
CGATyrian Announces Rights Issue
31/07/09PRICE SENSITIVE
CGAAppendix 4C
31/07/09PRICE SENSITIVE
CGATrading Halt
29/07/09PRICE SENSITIVE
CGACompany Newsletter - July 2009
13/07/09
CGACeasing to be a substantial holder
15/06/09
CGAChange in substantial holding
12/06/09
refresh Created with Sketch. REFRESH
 

Top Stories

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

The ASX200 has been really flirting with the 8,500pts mark this week, notching an intraweek ATH of 8,476pts.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
HotCopper Highlights: Your most watched stocks for Week 48, 2024 Good afternoon, a happy end of the week, and welcome to HotCopper Highlights – I’m Jonathon Davidson. Let’s get into it.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.